A public health approach to the prevention of inhibitors in hemophilia.

Soucie, J Michael; Miller, Connie H; Kelly, Fiona M; Oakley, Meredith; Brown, Deborah L; Kucab, Phillip

Soucie, J Michael; Miller, Connie H; Kelly, Fiona M; Oakley, Meredith; Brown, Deborah L; Kucab, Phillip.

Afiliación

Soucie JM; Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, Georgia. Electronic address: msoucie@cdc.gov.
Miller CH; Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, Georgia.
Kelly FM; Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, Georgia.
Oakley M; Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, Georgia.
Brown DL; University of Texas Health Science Center, MD Anderson Cancer Center and Gulf States Hemophilia and Thrombophilia Treatment Center, Houston, Texas.
Kucab P; Wayne State University School of Medicine, Detroit, Michigan.

Am J Prev Med ; 47(5): 669-73, 2014 Nov.

Article en En | MEDLINE | ID: mdl-25245801

Asunto(s)

Hemofilia A/terapia; Redes Comunitarias; Hemofilia A/epidemiología; Humanos; Vigilancia de la Población; Salud Pública/métodos; Factores de Riesgo; Estados Unidos/epidemiología

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hemofilia A Tipo de estudio: Etiology_studies / Risk_factors_studies / Screening_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Am J Prev Med Asunto de la revista: SAUDE PUBLICA Año: 2014 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google